Related Experiment Videos
[Cardiomyopathies. VIII. Sudden death in hypertrophic cardiomyopathy]
1Departamento de Exloración Cardiopulmonar, Hospital Universitario San Carlos, Madrid.
Insights
Sudden death (SD) is a risk for hypertrophic cardiomyopathy (HCM) patients. Identifying high-risk individuals and understanding genetic factors are key to preventing SD in HCM.
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) poses a significant risk of sudden death (SD).
- Identifying and managing HCM patients at high risk for SD is a major clinical challenge.
- The precise causes of SD in HCM are often unclear, though genetic factors are increasingly recognized.
Purpose of the Study:
- To review the assessment of high-risk patients with HCM.
- To explore potential mechanisms underlying SD in HCM.
- To address critical unanswered questions regarding SD prevention and treatment in HCM.
Main Methods:
- This is a review article.
- It synthesizes current knowledge on HCM, SD, and risk stratification.
- Focuses on clinical assessment, genetic factors, and arrhythmias.
Main Results:
- Ventricular arrhythmias are the most reliable predictor of SD in HCM.
- Genetic factors play a crucial role in HCM prognosis and life expectancy.
- Current understanding of SD mechanisms in HCM is incomplete.
Conclusions:
- Accurate risk stratification for SD in HCM remains a significant clinical challenge.
- Further research is needed to elucidate SD mechanisms and improve prevention strategies.
- Genetic profiling and arrhythmia monitoring are vital for managing HCM patients at risk of SD.
Abstract:
The natural history of patients with hypertrophic cardiomyopathy (HCM) may be shadowed by the appearance of sudden death (SD). The identification and management of patients with HCM who are at increased risk of SD remains a major problem and a clinical challenge. Several mechanisms have been implicated in the pathogenesis of the disease, its symptomatic status and prognosis. However, the definitive cause of SD in HCM is rarely ascertainable. Genetic factors are emerging as new and important determinants of life expectancy among affected individuals. Conversely, ventricular arrhythmias remain the most useful single factor in the prediction of SD. In this review we highlight the assessment of patients at high risk, potential mechanisms of SD and major unanswered issues concerning prevention and treatment.